Novo Nordisk A/S (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 91   

Articles published

NVO 49.03 +0.56 (1.16%)
price chart
Sanofi Still Ahead Of Novo Nordisk In Insulin Drug Race
Novo Nordisk A/S (ADR) (NVO) announced yesterday, that its insulin therapy Tresiba, which was in late-stage trials, has proved to be safe and effective for the treatment of type 1 diabetes in children and young adults.
Related articles »  
Novo, Orexigen Join Race For Obesity Drugs; Arena-Eisai's Belviq And Vivus's ...
Novo Nordisk A/S (ADR) (NVO) received Food and Drug Administration's (FDA) advisory committee's approval on September 11 for its weight-loss therapy Saxenda, which was earlier prescribed as a treatment for diabetes.
Related articles »  
Corporate Updates: KMG Chemicals, Inc. (NYSE:KMG), Novo Nordisk A/S (ADR ...
Novo Nordisk A/S (ADR) (NYSE:NVO) recently updated that the EMDAC (Endocrinologic and Metabolic Drugs Advisory Committee) of the U.S.
FDA Expected To Approve Two More Weight Loss Drugs
On the same day, the regulator has invited its advisors to come together and discuss Novo Nordisk A/S' (ADR) (NVO) intravenous injection to combat obesity.
Related articles »  
US Pharma Sales Growth Rebounds
Of these, AbbVie Inc. (ABBV), Novo Nordisk A/S ADR (NVO), and Bayer AG ADR (BAYRY) are expected to see their revenues compound at the highest annual growth rates of 9.6%, 8.9%, and 6.1%, respectively, over the next three years starting from August ...
Watch List - Novo Nordisk A/S (ADR) (NYSE:NVO), Cisco Systems, Inc ...
Manhattan, NY- 11 September, 2014 - (Techsonian) - Novo Nordisk A/S (ADR) (NYSE:NVO) engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark.
Related articles »  
Watch List -Novo Nordisk A/S (ADR) (NYSE:NVO), FirstEnergy Corp. (NYSE:FE ...
Manhattan, NY- September 12, 2014 - (Techsonian) �Novo Nordisk A/S (ADR)( NYSE:NVO)engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark.
Related articles »  
Blistering Penny Stocks in the News - Novo Nordisk A/S (NVO), AbbVieInc ...
Miami, Florida - 18 Sep, 2014 - (Tech Sonian)Novo Nordisk A/S (ADR) (NYSE:NVO)is announcing �Innovation in Diabetes Care: 90 Years and Beyond� at the MaRS Discovery District, to highlight the significant contribution Canada has made to diabetes care ...
Related articles »  
European stocks dip: Nokia Corporation (NYSE:NOK), Novo Nordisk A/S (NVO ...
Shares of Novo Nordisk A/S (ADR) (NYSE:NVO) were 46.41% off 52 week lows as of the latest close and -1.57% below the 52 week high.
Pharma Stocks: What To Look For In The Week Ahead
... Auxilium Pharmaceuticals, Inc. (AUXL) and Clarus Therapeutics, Inc's testosterone drugs. AstraZeneca, Novo Nordisk A/S (ADR) (NVO) and Eli Lilly and Co (LLY) will present at the annual meeting of European Association for the Study of Diabetes (EASD).